Clinical Trials Directory

Trials / Completed

CompletedNCT04215770

Comparison of Intravenous Co-amoxiclav Versus Benzyl Penicillin

Comparison of Intravenous Co-amoxiclav Versus Benzyl Penicillin in Children With Severe Tonsillitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
310 (actual)
Sponsor
Combined Military Hospital, Pakistan · Academic / Other
Sex
All
Age
5 Years – 15 Years
Healthy volunteers
Not accepted

Summary

To compare intravenous Co-amoxiclav versus Benzyl penicillin in children with severe streptococcal tonsillitis in terms of efficacy, safety and cost effectiveness.

Detailed description

Efficacy was measured through improvement (decrease in fever, settling lymphadenopathy and disappearance of tonsillar exudate) in Centor Criteria score on daily basis. Improvement i.e reduction in Centor Criteria score was recorded for all children till full recovery. Safety was measured by frequency of hypersensitivity reactions or severe side effects of antibiotics necessitating stoppage of the drug. All the children in both Groups were given test dose of the antibiotic before giving full dose of antibiotic prescribed. Cost effectiveness was compared in terms of total cost of injections (Co-amoxiclav versus Benzyl penicillin) which were administered to children in both groups.

Conditions

Interventions

TypeNameDescription
DRUGinj co-amoxiclav 50 units/kg/day vs inj Benzyl Penicillin 25000 units/kg/dayPatients of both groups were examined and compared in terms of efficacy of treatment, safety and cost effectiveness

Timeline

Start date
2018-01-01
Primary completion
2019-11-01
Completion
2019-11-01
First posted
2020-01-02
Last updated
2020-01-03

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT04215770. Inclusion in this directory is not an endorsement.